Butrans



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 64.3%
Pain 24.3%
Analgesic Therapy 3.1%
Back Pain 2.9%
Breakthrough Pain 1.6%
Arthralgia 0.6%
Fibromyalgia 0.5%
Neck Pain 0.4%
Neuralgia 0.4%
Osteoarthritis 0.3%
Pain In Extremity 0.2%
Depression 0.2%
Drug Abuse 0.2%
Blood Pressure 0.2%
Arthritis 0.2%
Insomnia 0.2%
Anxiety 0.1%
Migraine 0.1%
Muscle Spasms 0.1%
Headache 0.1%
Inadequate Analgesia 15.4%
Drug Ineffective 14.8%
Application Site Rash 10.3%
Nausea 10.1%
Rash 5.9%
Application Site Irritation 5.2%
Product Adhesion Issue 4.5%
Drug Effect Decreased 4.4%
Application Site Reaction 3.3%
Application Site Pruritus 3.1%
Vomiting 2.9%
Pain 2.6%
Headache 2.6%
Application Site Vesicles 2.5%
Dizziness 2.4%
Wrong Technique In Drug Usage Process 2.4%
Somnolence 2.3%
Feeling Abnormal 2.0%
Skin Irritation 1.8%
Extra Dose Administered 1.5%
Secondary
Product Used For Unknown Indication 41.0%
Pain 28.3%
Back Pain 6.9%
Breakthrough Pain 3.4%
Analgesic Therapy 2.8%
Fibromyalgia 2.6%
Arthralgia 2.6%
Symphysiolysis 2.3%
Neck Pain 1.9%
Osteoarthritis 1.3%
Neuralgia 1.0%
Pain In Extremity 1.0%
Anxiety 0.9%
Arthritis 0.8%
Muscle Spasms 0.7%
Insomnia 0.6%
Intervertebral Disc Degeneration 0.6%
Depression 0.5%
Convulsion 0.4%
Spinal Osteoarthritis 0.4%
Inadequate Analgesia 31.6%
Drug Ineffective 11.6%
Nausea 8.8%
Product Adhesion Issue 6.2%
Extra Dose Administered 6.1%
Pain 5.6%
Vomiting 4.5%
Somnolence 4.1%
Wrong Technique In Drug Usage Process 3.7%
Application Site Rash 2.0%
Application Site Vesicles 2.0%
Rash 1.9%
Tremor 1.9%
Unevaluable Event 1.7%
Drug Effect Decreased 1.6%
Feeling Abnormal 1.6%
Headache 1.6%
Palpitations 1.3%
Product Quality Issue 1.3%
Skin Irritation 1.2%
Concomitant
Product Used For Unknown Indication 47.2%
Pain 10.3%
Rheumatoid Arthritis 5.6%
Urinary Tract Infection 3.6%
Crohn's Disease 3.5%
Back Pain 3.0%
Hypertension 2.9%
Multiple Myeloma 2.6%
Osteoporosis 2.6%
Analgesic Therapy 2.4%
Prophylaxis 2.0%
Constipation 1.8%
Grand Mal Convulsion 1.8%
Abnormal Behaviour 1.7%
Anxiety 1.7%
Gastrooesophageal Reflux Disease 1.7%
Nausea 1.7%
Neuralgia 1.5%
Diabetes Mellitus 1.4%
Dyspepsia 1.4%
Somnolence 8.3%
Vomiting 8.3%
Urinary Tract Infection 6.9%
Blood Creatine Phosphokinase Increased 5.6%
Convulsion 5.6%
Diarrhoea 5.6%
Drug Ineffective 5.6%
Renal Failure Acute 5.6%
Sepsis 5.6%
Dehydration 4.2%
Drug Abuse 4.2%
Eye Pain 4.2%
Hypercalcaemia 4.2%
Nausea 4.2%
Pain 4.2%
Tardive Dyskinesia 4.2%
Weight Decreased 4.2%
Weight Increased 4.2%
Anaemia 2.8%
Back Pain 2.8%
Interacting
Product Used For Unknown Indication 32.3%
Back Pain 16.9%
Convulsion 6.2%
Anxiety 5.4%
Blood Pressure Increased 5.4%
Depression 5.4%
Muscle Spasms 5.4%
Urinary Tract Infection 5.4%
Pain 4.6%
Addison's Disease 1.5%
Arthralgia 1.5%
Breast Cancer 1.5%
Colitis 1.5%
Crohn's Disease 1.5%
Inflammation 1.5%
Blood Cholesterol Increased 0.8%
Breakthrough Pain 0.8%
Cancer Pain 0.8%
Hypertension 0.8%
Musculoskeletal Chest Pain 0.8%
Vomiting 33.3%
Balance Disorder 16.7%
Suicidal Ideation 16.7%
Nausea 8.3%
Dizziness 4.2%
Drug Interaction 4.2%
Joint Swelling 4.2%
Product Taste Abnormal 4.2%
Pyrexia 4.2%
Supraventricular Tachycardia 4.2%